Evercore ISI Remains a Buy on C4 Therapeutics (CCCC)
at www.tipranks.com (Thu, 18-Dec 6:56 AM)
Barclays Keeps Their Buy Rating on C4 Therapeutics (CCCC)
at www.tipranks.com (Wed, 17-Dec 4:17 AM)
C4 Therapeutics Secures $125 Million in New Funding to Accelerate Cemsidomide Trials—Warrants Structure Could Unlock $225 Million More
Market Chameleon (Thu, 16-Oct 11:22 AM)
